Jeremy VisserOct 15, 20231 minEADV 2023 Day 4 Afternoon: JAK Inhibitors and Inflammatory Skin DiseaseDr. Ronald B. Vender gives insights into JAK inhibitors and patient aspects of skin diseases at the 2023 EADV Congress in Berlin.
Jeremy VisserOct 15, 20231 minEADV 2023 Day 4 Morning: Congress Presentations of InterestDr. Ronald B. Vender recaps the most popular presentations at the 2023 EADV Congress in Berlin.
Jeremy VisserOct 14, 20231 minEADV 2023 Day 3 Evening: Abrocitinib for Prurigo Nodularis in Chronic PruritisDr. Fiona Lovegrove reports on a late breaking presentation about the efficacy and safety of abrocitinib at the 2023 EADV Congress in Berlin
Jeremy VisserOct 14, 20231 minEADV 2023 Day 3 Afternoon: Efficacy and Safety of RezpegaldesleukinDr. Fiona Lovegrove reports on the late breaking presentation on rezpegaldesleukin at the 2023 EADV Congress in Berlin.